{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:41:53Z","timestamp":1794004913997,"version":"4.8.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-025-02599-7","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T10:58:34Z","timestamp":1742295514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Incidence and predictors of lower extremity lymphedema after postoperative radiotherapy for prostate cancer"],"prefix":"10.1186","volume":"20","author":[{"given":"Giuseppe","family":"Facondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bottero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Goanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Farneti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Faiella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasqualina","family":"D\u2019Urso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Sanguineti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"issue":"11","key":"2599_CR1","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1136\/ijgc-2020-001682","volume":"30","author":"AF Bona","year":"2020","unstructured":"Bona AF, Ferreira KR, Carvalho RBM, Thuler LCS, Bergmann A. Incidence, prevalence, and factors associated with lymphedema after treatment for cervical cancer: a systematic review. Int J Gynecol Cancer. 2020;30(11):1697\u2013704.","journal-title":"Int J Gynecol Cancer"},{"issue":"2 Pt 1","key":"2599_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/AOG.0000000000000372","volume":"124","author":"KJ Yost","year":"2014","unstructured":"Yost KJ, Cheville AL, Al-Hilli MM, Mariani A, Barrette BA, McGree ME, Weaver AL, Dowdy SC. Lymphedema after surgery for endometrial cancer: prevalence, risk factors, and quality of life. Obstet Gynecol. 2014;124(2 Pt 1):307\u201315.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2599_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.eururo.2016.12.003","volume":"72","author":"N Fossati","year":"2017","unstructured":"Fossati N, Willemse PM, Van den Broeck T, van den Bergh RCN, Yuan CY, Briers E, Bellmunt J, Bolla M, Cornford P, De Santis M, et al. The benefits and Harms of different extents of Lymph Node Dissection during Radical Prostatectomy for prostate Cancer: a systematic review. Eur Urol. 2017;72(1):84\u2013109.","journal-title":"Eur Urol"},{"issue":"5","key":"2599_CR4","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.eururo.2020.11.040","volume":"79","author":"JFP Lestingi","year":"2021","unstructured":"Lestingi JFP, Guglielmetti GB, Trinh QD, Coelho RF, Pontes J Jr., Bastos DA, Cordeiro MD, Sarkis AS, Faraj SF, Mitre AI, et al. Extended Versus Limited Pelvic Lymph Node Dissection during Radical Prostatectomy for Intermediate- and high-risk prostate Cancer: early oncological outcomes from a Randomized Phase 3 Trial. Eur Urol. 2021;79(5):595\u2013604.","journal-title":"Eur Urol"},{"issue":"4","key":"2599_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.eururo.2022.06.002","volume":"82","author":"G Gandaglia","year":"2022","unstructured":"Gandaglia G, Mazzone E, Stabile A, Pellegrino A, Cucchiara V, Barletta F, Scuderi S, Robesti D, Leni R, Samanes Gajate AM, et al. Prostate-specific membrane antigen radioguided surgery to detect nodal metastases in primary prostate Cancer patients undergoing Robot-assisted radical prostatectomy and extended pelvic lymph node dissection: results of a planned interim analysis of a prospective phase 2 study. Eur Urol. 2022;82(4):411\u20138.","journal-title":"Eur Urol"},{"issue":"1","key":"2599_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12957-023-02932-y","volume":"21","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhang G, Wang J, Bi J. Different lymph node dissection ranges during radical prostatectomy for patients with prostate cancer: a systematic review and network meta-analysis. World J Surg Oncol. 2023;21(1):80.","journal-title":"World J Surg Oncol"},{"issue":"3","key":"2599_CR7","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s10147-017-1223-x","volume":"23","author":"S Morizane","year":"2018","unstructured":"Morizane S, Honda M, Fukasawa S, Komaru A, Inokuchi J, Eto M, Shimbo M, Hattori K, Kawano Y, Takenaka A. Comparison of the diagnostic efficacy and perioperative outcomes of limited versus extended pelvic lymphadenectomy during robot-assisted radical prostatectomy: a multi-institutional retrospective study in Japan. Int J Clin Oncol. 2018;23(3):568\u201375.","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"2599_CR8","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.eururo.2006.08.015","volume":"50","author":"A Briganti","year":"2006","unstructured":"Briganti A, Chun FK, Salonia A, Suardi N, Gallina A, Da Pozzo LF, Roscigno M, Zanni G, Valiquette L, Rigatti P, et al. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol. 2006;50(5):1006\u201313.","journal-title":"Eur Urol"},{"issue":"10","key":"2599_CR9","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S1470-2045(20)30456-3","volume":"21","author":"A Kneebone","year":"2020","unstructured":"Kneebone A, Fraser-Browne C, Duchesne GM, Fisher R, Frydenberg M, Herschtal A, Williams SG, Brown C, Delprado W, Haworth A, et al. Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03\/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial. Lancet Oncol. 2020;21(10):1331\u201340.","journal-title":"Lancet Oncol"},{"issue":"10260","key":"2599_CR10","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S0140-6736(20)31553-1","volume":"396","author":"CC Parker","year":"2020","unstructured":"Parker CC, Clarke NW, Cook AD, Kynaston HG, Petersen PM, Catton C, Cross W, Logue J, Parulekar W, Payne H, et al. Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial. Lancet. 2020;396(10260):1413\u201321.","journal-title":"Lancet"},{"issue":"10","key":"2599_CR11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S1470-2045(20)30454-X","volume":"21","author":"P Sargos","year":"2020","unstructured":"Sargos P, Chabaud S, Latorzeff I, Magne N, Benyoucef A, Supiot S, Pasquier D, Abdiche MS, Gilliot O, Graff-Cailleaud P, et al. Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial. Lancet Oncol. 2020;21(10):1341\u201352.","journal-title":"Lancet Oncol"},{"key":"2599_CR12","doi-asserted-by":"crossref","unstructured":"Clinckaert A, Callens K, Cooreman A, Bijnens A, Moris L, Van Calster C, Geraerts I, Joniau S, Everaerts W. The Prevalence of Lower Limb and Genital Lymphedema after Prostate Cancer Treatment: A Systematic Review. Cancers (Basel) 2022, 14(22).","DOI":"10.3390\/cancers14225667"},{"issue":"10","key":"2599_CR13","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1080\/0284186X.2023.2251669","volume":"62","author":"L Fokdal","year":"2023","unstructured":"Fokdal L, Berg M, Zedan AH, Mortensen B, Nissen HD, Bentzen L, Svenson M, Madsen CV. Patient-reported lower limb edema after primary radiotherapy for prostate cancer. Acta Oncol. 2023;62(10):1279\u201385.","journal-title":"Acta Oncol"},{"issue":"1","key":"2599_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0360-3016(94)90138-4","volume":"28","author":"M Roach","year":"1994","unstructured":"Roach M 3rd, Marquez C, Yuo HS, Narayan P, Coleman L, Nseyo UO, Navvab Z, Carroll PR. Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1994;28(1):33\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2599_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/JU.0000000000000295","volume":"202","author":"TM Pisansky","year":"2019","unstructured":"Pisansky TM, Thompson IM, Valicenti RK, D\u2019Amico AV, Selvarajah S. Adjuvant and Salvage Radiotherapy after Prostatectomy: ASTRO\/AUA Guideline Amendment 2018\u20132019. J Urol. 2019;202(3):533\u20138.","journal-title":"J Urol"},{"issue":"1","key":"2599_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/0300891620908950","volume":"107","author":"G Sanguineti","year":"2021","unstructured":"Sanguineti G, Bertini L, Faiella A, Ferriero MC, Marzi S, Farneti A, Landoni V. Response on DCE-MRI predicts outcome of salvage radiotherapy for local recurrence after radical prostatectomy. Tumori. 2021;107(1):55\u201363.","journal-title":"Tumori"},{"key":"2599_CR17","doi-asserted-by":"crossref","unstructured":"Faiella A, Sciuto R, Giannarelli D, Bottero M, Farneti A, Bertini L, Rea S, Landoni V, Vici P, Ferriero MC et al. A Prospective Study Assessing the Post-Prostatectomy Detection Rate of a Presumed Local Failure at mpMR with Either (64)CuCl(2) or (64)CuPSMA PET\/CT. Cancers (Basel) 2021, 13(21).","DOI":"10.3390\/cancers13215564"},{"issue":"2","key":"2599_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ijrobp.2008.08.002","volume":"74","author":"CA Lawton","year":"2009","unstructured":"Lawton CA, Michalski J, El-Naqa I, Buyyounouski MK, Lee WR, Menard C, O\u2019Meara E, Rosenthal SA, Ritter M, Seider M. RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2009;74(2):383\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2599_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ijrobp.2020.08.034","volume":"109","author":"WA Hall","year":"2021","unstructured":"Hall WA, Paulson E, Davis BJ, Spratt DE, Morgan TM, Dearnaley D, Tree AC, Efstathiou JA, Harisinghani M, Jani AB, et al. NRG Oncology Updated International Consensus Atlas on pelvic lymph node volumes for Intact and postoperative prostate Cancer. Int J Radiat Oncol Biol Phys. 2021;109(1):174\u201385.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2599_CR20","first-page":"3","volume":"53","author":"Executive Committee of the International Society of L","year":"2020","unstructured":"Executive Committee of the International Society of L. The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology. Lymphology. 2020;53(1):3\u201319.","journal-title":"Lymphology"},{"key":"2599_CR21","unstructured":"Lymphoedema framework. Best Practice for the Management of Lymphoedema. International consensus. In., edn. London: Mep ltd 2006; 2006."},{"issue":"12","key":"2599_CR22","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1093\/ptj\/82.12.1201","volume":"82","author":"AP Sander","year":"2002","unstructured":"Sander AP, Hajer NM, Hemenway K, Miller AC. Upper-extremity volume measurements in women with lymphedema: a comparison of measurements obtained via water displacement with geometrically determined volume. Phys Ther. 2002;82(12):1201\u201312.","journal-title":"Phys Ther"},{"key":"2599_CR23","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1186\/s40064-015-1468-7","volume":"4","author":"A Chromy","year":"2015","unstructured":"Chromy A, Zalud L, Dobsak P, Suskevic I, Mrkvicova V. Limb volume measurements: comparison of accuracy and decisive parameters of the most used present methods. Springerplus. 2015;4:707.","journal-title":"Springerplus"},{"issue":"3","key":"2599_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s40618-017-0746-3","volume":"41","author":"MA Minetto","year":"2018","unstructured":"Minetto MA, Motta G, Gorji NE, Lucini D, Biolo G, Pigozzi F, Portincasa P, Maffiuletti NA. Reproducibility and validity of the Italian version of the International Physical Activity Questionnaire in obese and diabetic patients. J Endocrinol Invest. 2018;41(3):343\u20139.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2599_CR25","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/jso.1158","volume":"78","author":"M Franchi","year":"2001","unstructured":"Franchi M, Ghezzi F, Riva C, Miglierina M, Buttarelli M, Bolis P. Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer. J Surg Oncol. 2001;78(4):232\u20137. discussion 237\u2013240.","journal-title":"J Surg Oncol"},{"issue":"1","key":"2599_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1089\/lrb.2012.0015","volume":"11","author":"Y Cemal","year":"2013","unstructured":"Cemal Y, Jewell S, Albornoz CR, Pusic A, Mehrara BJ. Systematic review of quality of life and patient reported outcomes in patients with oncologic related lower extremity lymphedema. Lymphat Res Biol. 2013;11(1):14\u20139.","journal-title":"Lymphat Res Biol"},{"issue":"6","key":"2599_CR27","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"14","author":"T DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500\u201315.","journal-title":"Lancet Oncol"},{"issue":"4","key":"2599_CR28","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.ijrobp.2014.12.029","volume":"91","author":"RA Chandra","year":"2015","unstructured":"Chandra RA, Miller CL, Skolny MN, Warren LE, Horick N, Jammallo LS, Sadek BT, Shenouda MN, O\u2019Toole J, Specht MC, et al. Radiation therapy risk factors for development of lymphedema in patients treated with regional lymph node irradiation for breast cancer. Int J Radiat Oncol Biol Phys. 2015;91(4):760\u20134.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2599_CR29","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/ijgc-2018-000084","volume":"29","author":"L Volpi","year":"2019","unstructured":"Volpi L, Sozzi G, Capozzi VA, Ricco M, Merisio C, Di Serio M, Chiantera V, Berretta R. Long term complications following pelvic and para-aortic lymphadenectomy for endometrial cancer, incidence and potential risk factors: a single institution experience. Int J Gynecol Cancer. 2019;29(2):312\u20139.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"2599_CR30","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.ygyno.2006.03.055","volume":"103","author":"NR Abu-Rustum","year":"2006","unstructured":"Abu-Rustum NR, Alektiar K, Iasonos A, Lev G, Sonoda Y, Aghajanian C, Chi DS, Barakat RR. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol. 2006;103(2):714\u20138.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2599_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0022-5347(05)64055-4","volume":"169","author":"T Clark","year":"2003","unstructured":"Clark T, Parekh DJ, Cookson MS, Chang SS, Smith ER Jr., Wells N, Smith J Jr. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol. 2003;169(1):145\u20137. discussion 147\u2013148.","journal-title":"J Urol"},{"issue":"10","key":"2599_CR32","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(81)90029-8","volume":"7","author":"MV Pilepich","year":"1981","unstructured":"Pilepich MV, Perez CA, Walz BJ, Zivnuska FR. Complications of definitive radiotherapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1981;7(10):1341\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"2599_CR33","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/0360-3016(85)90086-0","volume":"11","author":"JD Forman","year":"1985","unstructured":"Forman JD, Zinreich E, Lee DJ, Wharam MD, Baumgardner RA, Order SE. Improving the therapeutic ratio of external beam irradiation for carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1985;11(12):2073\u201380.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2599_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejso.2012.10.011","volume":"39","author":"A Achouri","year":"2013","unstructured":"Achouri A, Huchon C, Bats AS, Bensaid C, Nos C, Lecuru F. Complications of lymphadenectomy for gynecologic cancer. Eur J Surg Oncol. 2013;39(1):81\u20136.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"2599_CR35","doi-asserted-by":"publisher","first-page":"596","DOI":"10.21037\/gs.2020.03.20","volume":"9","author":"O Allam","year":"2020","unstructured":"Allam O, Park KE, Chandler L, Mozaffari MA, Ahmad M, Lu X, Alperovich M. The impact of radiation on lymphedema: a review of the literature. Gland Surg. 2020;9(2):596\u2013602.","journal-title":"Gland Surg"},{"issue":"1","key":"2599_CR36","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.3802\/jgo.2016.27.e4","volume":"27","author":"D Mitra","year":"2016","unstructured":"Mitra D, Catalano PJ, Cimbak N, Damato AL, Muto MG, Viswanathan AN. The risk of lymphedema after postoperative radiation therapy in endometrial cancer. J Gynecol Oncol. 2016;27(1):e4.","journal-title":"J Gynecol Oncol"},{"key":"2599_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/1748-717X-8-271","volume":"8","author":"E Rasmusson","year":"2013","unstructured":"Rasmusson E, Gunnlaugsson A, Blom R, Bjork-Eriksson T, Nilsson P, Ahlgen G, Jonsson C, Johansson K, Kjellen E. Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer. Radiat Oncol. 2013;8:271.","journal-title":"Radiat Oncol"},{"issue":"1","key":"2599_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12905-017-0403-1","volume":"17","author":"K Kuroda","year":"2017","unstructured":"Kuroda K, Yamamoto Y, Yanagisawa M, Kawata A, Akiba N, Suzuki K, Naritaka K. Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study. BMC Womens Health. 2017;17(1):50.","journal-title":"BMC Womens Health"},{"issue":"3","key":"2599_CR39","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ygyno.2017.06.004","volume":"146","author":"SC Hayes","year":"2017","unstructured":"Hayes SC, Janda M, Ward LC, Reul-Hirche H, Steele ML, Carter J, Quinn M, Cornish B, Obermair A. Lymphedema following gynecological cancer: results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors. Gynecol Oncol. 2017;146(3):623\u20139.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"2599_CR40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/PRS.0000000000007021","volume":"146","author":"AK Greene","year":"2020","unstructured":"Greene AK, Zurakowski D, Goss JA. Body Mass Index and Lymphedema Morbidity: comparison of obese versus normal-weight patients. Plast Reconstr Surg. 2020;146(2):402\u20137.","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"2599_CR41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ygyno.2019.11.003","volume":"156","author":"MM Leitao Jr","year":"2020","unstructured":"Leitao MM Jr., Zhou QC, Gomez-Hidalgo NR, Iasonos A, Baser R, Mezzancello M, Chang K, Ward J, Chi DS, Long Roche K, et al. Patient-reported outcomes after surgery for endometrial carcinoma: prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy. Gynecol Oncol. 2020;156(1):147\u201353.","journal-title":"Gynecol Oncol"},{"key":"2599_CR42","doi-asserted-by":"crossref","unstructured":"Parker CC, Petersen PM, Cook AD, Clarke NW, Catton C, Cross WR, Kynaston H, Parulekar WR, Persad RA, Saad F et al. Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047). Ann Oncol 2024.","DOI":"10.1016\/j.annonc.2024.05.001"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02599-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-025-02599-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02599-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T10:58:38Z","timestamp":1742295518000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-025-02599-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2599"],"URL":"https:\/\/doi.org\/10.1186\/s13014-025-02599-7","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of the \u2018Regina Elena\u2019 National Cancer Institute (protocol code 946\/17) and approved 13 June 2017.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}